
Economic Burden and Systemwide Strategies
Panelists discuss how the economic toll of poor LDL-C control demands workplace and systemwide prevention strategies.
Episodes in this series

Panelists discuss how poor low-density lipoprotein cholesterol (LDL-C) control imposes substantial economic costs through hospitalizations, lost productivity, and long-term treatment of cardiovascular events.
They highlight that preventive strategies—such as workplace screenings and wellness incentives—can improve early detection and reduce downstream costs.
Panelists conclude that systemwide coordination between employers, payers, and clinicians is necessary to make cholesterol control a sustainable public health priority.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.









































